Phase II Clinical Trial of Adjuvant Anlotinib in Patients with Stage IA Non-Small Cell Lung Cancer at High Risk of Recurrence
Latest Information Update: 01 Dec 2020
At a glance
- Drugs Catequentinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 01 Dec 2020 New trial record